search

Vivani Medical Inc. (VANI)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Vivani Medical's Cortigent-ClearOne Merger Delayed Pending Final Regulatory Approval
Oct 30, 2026

Vivani Medical's Cortigent-ClearOne Merger Delayed Pending Final Regulatory Approval

Vivani Medical, Inc. (NASDAQ:VANI) announced that the expected October 2026 completion of its Cortigent-ClearOne merger has been postponed. The delay is due to pending final regulatory clearance for the deal, which involves Cortigent, a wholly-owned subsidiary of Vivani Medical, merging into CLRO Merger Sub, Inc. and becoming a wholly-owned subsidiary of ClearOne, Inc. The parties anticipate the closing will take place shortly after receiving this approval.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral